AGING IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION IN HEALTHY-MEN YEARS BEFORE THE AGE-RELATED DECLINE IN WOMEN

被引:1052
作者
CELERMAJER, DS
SORENSEN, KE
SPIEGELHALTER, DJ
GEORGAKOPOULOS, D
ROBINSON, J
DEANFIELD, JE
机构
[1] HOSP SICK CHILDREN,CARDIOTHORAC UNIT,LONDON,ENGLAND
[2] MRC,BIOSTAT UNIT,CAMBRIDGE CB2 2BW,ENGLAND
关键词
D O I
10.1016/0735-1097(94)90305-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study assessed whether aging is associated with progressive endothelial dysfunction, whether the pattern of any age-related decline in vascular health is different in men and women and whether any gender difference is consistent with known changes in hormonal status. Background. Coronary and cerebrovascular disease are much less common in young and middle aged women compared with men, although the gender difference in death from atherosclerosis is less marked after the menopause. Endothelial dysfunction is an early event in atherogenesis and is important in dynamic plaque stenosis in later life. The effect of aging on endothelial function in men and women, however, is not well known. Methods. We used high resolution ultrasound to study endothelium-dependent and endothelium-independent vascular responses. Brachial artery physiology was investigated in 238 subjects (103 men, 135 women; mean [+/-SD] age 38 +/- 17 years, range 15 to 72) with no known risk factors for atherosclerosis. The responses to reactive hyperemia (flow-mediated dilation, which is endothelium dependent) and to glyceryl trinitrate (an endothelium-independent dilator) were assessed for all the subjects and then for men and women separately. Results. On multivariate analysis for the whole group, reduced flow-mediated dilation was related to older age (r = -0.34, p < 0.0001). In men, flow mediated dilation was preserved in subjects aged less than or equal to 40 years but declined thereafter at 0.2l%/year. In women, flow-mediated dilation was stable until the early 50s, after which it declined at 0.49%/year (p = 0.002 compared with men). In contrast, there was no significant change in the glyceryl trinitrate response with aging in either gender. Conclusions. Aging is associated with progressive endothelial dysfunction in normal humans, and this appears to occur earlier in men than in women. In women, however, a steep decline commences at around the time of the menopause. This is consistent with a protective effect of estrogens on the arterial wall.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 42 条
  • [11] GAMBRELL RD, 1991, AM J OBSTET GYNECOL, V165, P307
  • [12] GANGAR KF, 1991, LANCET, V338, P839
  • [13] SEX, PLASMA-LIPOPROTEINS, AND ATHEROSCLEROSIS - PREVAILING ASSUMPTIONS AND OUTSTANDING QUESTIONS
    GODSLAND, IF
    WYNN, V
    CROOK, D
    MILLER, NE
    [J]. AMERICAN HEART JOURNAL, 1987, 114 (06) : 1467 - 1503
  • [14] ESTROGEN MONOTHERAPY AND COMBINED ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY ATTENUATE AORTIC ACCUMULATION OF CHOLESTEROL IN OVARIECTOMIZED CHOLESTEROL-FED RABBITS
    HAARBO, J
    LETHESPENSEN, P
    STENDER, S
    CHRISTIANSEN, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) : 1274 - 1279
  • [15] INFERENCE IN 2-PHASE REGRESSION
    HINKLEY, DV
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1971, 66 (336) : 736 - 743
  • [16] REGULAR REVIEW - POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY
    JACOBS, HS
    LOEFFLER, FE
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6866): : 1403 - 1408
  • [17] CORONARY ARTERIOLAR MYOGENIC RESPONSE IS INDEPENDENT OF ENDOTHELIUM
    KUO, L
    CHILIAN, WM
    DAVIS, MJ
    [J]. CIRCULATION RESEARCH, 1990, 66 (03) : 860 - 866
  • [18] PARADOXICAL VASOCONSTRICTION INDUCED BY ACETYLCHOLINE IN ATHEROSCLEROTIC CORONARY-ARTERIES
    LUDMER, PL
    SELWYN, AP
    SHOOK, TL
    WAYNE, RR
    MUDGE, GH
    ALEXANDER, RW
    GANZ, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (17) : 1046 - 1051
  • [19] LOCAL AND SYSTEMIC ESTRADIOL-17-BETA - EFFECTS ON UTERINE AND SYSTEMIC VASODILATION
    MAGNESS, RR
    ROSENFELD, CR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (04): : E536 - E542
  • [20] MICKELSON JK, 1990, CARDIOVASCULAR PHARM, P293